These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37556245)

  • 1. Engagement with the HCV care cascade among high-risk groups: A population-based study.
    Erman A; Everett K; Wong WWL; Forouzannia F; Greenaway C; Janjua N; Kwong JC; Sander B
    Hepatol Commun; 2023 Sep; 7(9):. PubMed ID: 37556245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study.
    Mendlowitz AB; Bremner KE; Krahn M; Walker JD; Wong WWL; Sander B; Jones L; Isaranuwatchai W; Feld JJ
    CMAJ; 2023 Apr; 195(14):E499-E512. PubMed ID: 37040993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based Study.
    Passos-Castilho AM; Murphy DG; Blouin K; Benedetti A; Panagiotoglou D; Bruneau J; Klein MB; Kwong JC; Sander B; Janjua NZ; Greenaway C
    Viruses; 2024 Mar; 16(3):. PubMed ID: 38543755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.
    Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ
    Liver Int; 2019 Dec; 39(12):2261-2272. PubMed ID: 31444846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan.
    Huang MH; Sun HY; Ho SY; Chang SY; Hsieh SM; Sheng WH; Chuang YC; Huang YS; Su LH; Liu WC; Su YC; Hung CC
    World J Gastroenterol; 2021 Oct; 27(37):6277-6289. PubMed ID: 34712032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC).
    Janjua NZ; Kuo M; Yu A; Alvarez M; Wong S; Cook D; Wong J; Grebely J; Butt ZA; Samji H; Ramji A; Tyndall M; Krajden M
    EBioMedicine; 2016 Oct; 12():189-195. PubMed ID: 27596150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia.
    Averhoff F; Shadaker S; Gamkrelidze A; Kuchuloria T; Gvinjilia L; Getia V; Sergeenko D; Butsashvili M; Tsertsvadze T; Sharvadze L; Zarkua J; Skaggs B; Nasrullah M
    J Hepatol; 2020 Apr; 72(4):680-687. PubMed ID: 31811882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved Hepatitis C Cure Cascade Outcomes Among Urban Baby Boomers in the Direct-Acting Antiviral Era.
    Dupont SC; Fluker SA; Quairoli KM; Body C; Okosun I; Lom J; Miller LS
    Public Health Rep; 2020 Jan; 135(1):107-113. PubMed ID: 31756116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C care cascade in a large academic healthcare system, 2012 to 2018.
    Nakayama J; Hertzberg VS; Ho JC; Simpson RL; Cartwright EJ
    Medicine (Baltimore); 2023 Mar; 102(10):e32859. PubMed ID: 36897716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies.
    van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained virologic response from hepatitis C from an emergency department screening & linkage program: A retrospective review.
    Walter LA; Wilson L; Farmer M; Roberson T; Hand DT; Franco R
    Am J Emerg Med; 2023 Oct; 72():178-182. PubMed ID: 37540919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C care cascade before and during the direct-acting antiviral eras in New South Wales, Australia: A population-based linkage study.
    Yousafzai MT; Alavi M; Valerio H; Hajarizadeh B; Grebely J; Dore GJ
    J Viral Hepat; 2023 Mar; 30(3):250-261. PubMed ID: 36537024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus care cascade in persons experiencing homelessness in the United States in the era of direct-acting antiviral agents: A scoping review.
    Del Rosario A; Eldredge JD; Doorley S; Mishra SI; Kesler D; Page K
    J Viral Hepat; 2021 Nov; 28(11):1506-1514. PubMed ID: 34314081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.
    Rossi C; Butt ZA; Wong S; Buxton JA; Islam N; Yu A; Darvishian M; Gilbert M; Wong J; Chapinal N; Binka M; Alvarez M; Tyndall MW; Krajden M; Janjua NZ;
    J Hepatol; 2018 Nov; 69(5):1007-1014. PubMed ID: 30142429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs.
    Yeung A; Palmateer NE; Dillon JF; McDonald SA; Smith S; Barclay S; Hayes PC; Gunson RN; Templeton K; Goldberg DJ; Hickman M; Hutchinson SJ
    J Hepatol; 2022 Mar; 76(3):549-557. PubMed ID: 34634387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C Virus Reinfection in a Real-World Cohort of Homeless-Experienced Individuals in Boston.
    Beiser ME; Shaw LC; Shores SK; Carson JM; Hajarizadeh B
    Clin Infect Dis; 2023 Jul; 77(1):46-55. PubMed ID: 36869823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C Virus Screening and Care: Complexity of Implementation in Primary Care Practices Serving Disadvantaged Populations.
    Turner BJ; Rochat A; Lill S; Bobadilla R; Hernandez L; Choi A; Guerrero JA
    Ann Intern Med; 2019 Dec; 171(12):865-874. PubMed ID: 31791065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care utilization and costs associated with direct-acting antivirals for patients with substance use disorders and chronic hepatitis C.
    Jiang X; Vouri SM; Diaby V; Lo-Ciganic W; Parker R; Park H
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1388-1402. PubMed ID: 34595949
    [No Abstract]   [Full Text] [Related]  

  • 19. Late Relapse Versus Hepatitis C Virus Reinfection in Patients With Sustained Virologic Response After Sofosbuvir-Based Therapies.
    Sarrazin C; Isakov V; Svarovskaia ES; Hedskog C; Martin R; Chodavarapu K; Brainard DM; Miller MD; Mo H; Molina JM; Sulkowski MS
    Clin Infect Dis; 2017 Jan; 64(1):44-52. PubMed ID: 27737953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral hepatitis C cascade of care: A population-level comparison of immigrant and long-term residents.
    Yasseen AS; Kwong JC; Feld JJ; Janjua NZ; Greenaway C; Lapointe-Shaw L; Sherman M; Mazzulli T; Kustra R; MacDonald L; Sander B; Crowcroft NS
    Liver Int; 2021 Aug; 41(8):1775-1788. PubMed ID: 33655665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.